Plasma enzyme determinations in normal and dystrophic mice

Area of Science:

• Biochemistry
• Genetics
• Animal Models

Background:

• Plasma creatine kinase (CK) is an enzyme indicative of muscle integrity.
• Muscular dystrophy is a group of genetic disorders characterized by progressive muscle degeneration.

Purpose of the Study:

• To determine plasma creatine kinase (CK) levels in different mouse strains, including normal and dystrophic models.
• To establish baseline CK levels for comparison and identify potential biomarkers for muscular dystrophy.

Main Methods:

• Plasma samples were collected from normal CF1 and C57BL/6 mice, as well as C57BL/6J-dy dystrophic mice and their heterozygotes.
• Creatine kinase (CK) activity was measured in plasma using established biochemical assays.
• Statistical analysis was performed to compare CK levels across different groups and ages.

Main Results:

• Young dystrophic mice (under 80 days) exhibited significantly elevated plasma CK levels (mean 1186 mIU/ml) compared to normal mice (mean ~150-160 mIU/ml).
• A subset of four clinically normal littermates of dystrophic mice also showed elevated CK levels, suggesting potential genetic or environmental factors.
• CK levels in older dystrophic mice and heterozygotes were closer to normal ranges, indicating age-dependent changes.

Conclusions:

• Plasma CK levels are a sensitive indicator of muscle damage in C57BL/6J-dy dystrophic mice, particularly in younger animals.
• The study highlights the utility of CK as a biomarker for muscular dystrophy in mouse models.
• Further investigation is warranted to understand the elevated CK in some clinically normal littermates.